Progress in the prevention and treatment of Alzheimer's disease with traditional Chinese medicine

Erli FEI; Yun GU

doi:10.3969/j.issn.2096-5516.2025.01.010

PDF(808 KB)

Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2025, Vol. 8 ›› Issue (1) : 67-72. DOI: 10.3969/j.issn.2096-5516.2025.01.010

Progress in the prevention and treatment of Alzheimer's disease with traditional Chinese medicine

Erli FEI ,
Yun GU ^*

Author information +

History +

Abstract

Alzheimer's disease (AD) is a degenerative disease characterized by cognitive impairment, affecting over 50 million people worldwide. In recent years, the research progress of AD biomarkers and imaging diagnosis has brought new hope for the early detection and diagnosis of AD. The discovery of new pathways such as the brain-gut axis has led to the successful launch of new drugs such as GV-971, which has brought new options for the treatment of AD. But human understanding of AD is still the tip of the iceberg. Therefore, the anti-aging advantages of TCM are particularly important in the intervention of brain aging and AD. AD belongs to the category of "dementia" in traditional medicine, and traditional doctors have been fighting against it for more than 1,000 years, so TCM has a deep understanding of the treatment of "dementia", and many TCM theories coincide with modern medicine such as the brain-gut axis, which can provide more basis for the treatment of AD.

Key words

Alzheimer's disease / Dementia / Traditional Chinese Medicine

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Erli FEI , Yun GU. Progress in the prevention and treatment of Alzheimer's disease with traditional Chinese medicine[J]. Chinese Journal of Alzheimer's Disease and Related Disorders. 2025, 8(1): 67-72 https://doi.org/10.3969/j.issn.2096-5516.2025.01.010

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

[1]	Dissanayaka DMS, Jayasena V, Rainey-Smith SR, et al. The role of diet and gut microbiota in Alzheimer's disease[J]. Nutrients, 2024, 16(3):412. Cited in this article [2]

[2]	Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer's disease[J]. Lancet, 2021, 397(10284):1577-1590. Cited in this article [3]

[3]	Kumar A, Sidhu J, Goyal A, et al. Alzheimer Disease (Nursing) StatPearls Publishing[J]. Treasure Island, FL, USA, 2021. Cited in this article [1]

[4]	Zhang XX, Tian Y, Wang ZT, et al. The Epidemiology of Alzheimer's disease modifiable risk factors and prevention[J]. J Prev Alzheimers Dis, 2021, 8(3):313-321. Cited in this article [1]

[5]	2023 Alzheimer's disease facts and figures[J]. Alzheimers Dement, 2023, 19(4):1598-1695. PMID: 36918389 DOI: 10.1002/alz.13016 Cited in this article [1]

[6]	Bondi MW, Edmonds EC, Salmon DP, et al. Alzheimer's disease: past, present, and future[J]. J Int Neuropsychol Soc, 2017, 23(9-10):818-831. Cited in this article [3]

[7]	Scheltens P, Blennow K, Breteler MM, et al. Alzheimer's disease[J]. Lancet, 2016, 388(10043):505-517. Cited in this article [4]

[8]	Gate D, Saligrama N, Leventhal O, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease[J]. Nature, 2020, 577(7790):399-404. Cited in this article [1]

[9]	Da Mesquita S, Louveau A, Vaccari A, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease[J]. Nature, 2018, 560(7717):185-191. Cited in this article [1]

[10]	Dodiya HB, Frith M, Sidebottom A, et al. Synergistic depletion of gut microbial consortia, but not individual antibiotics, reduces amyloidosis in APPPS1-21 Alzheimer's transgenic mice[J]. Sci Rep, 2020, 10(1):8183. Cited in this article [1]

[11]	Jiang T, Zheng T, Li W, et al. IL-33/ST2 signaling pathway and Alzheimer's disease: a systematic review and meta-analysis[J]. Clin Neurol Neurosurg, 2023,230:107773. Cited in this article [1]

[12]	Trombella S, Assal F, Zekry D, et al. Imagerie cérébrale de la maladied'Alzheimer: état de l'art et perspectives pour le clinician Brain imaging of Alzheimer' disease: state of the art and perspectives for clinicians[J]. Rev Med Suisse, 2016, 12(515):795-798. Cited in this article [1]

[13]	Aschenbrenner AJ, Gordon BA, Benzinger TLS, et al. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease[J]. Neurology, 2018, 91(9):e859-e866. Cited in this article [2]

[14]	Ossenkoppele R, Rabinovici GD, Smith R, et al. Discriminative accuracy of [18F]flortaucipir positron emission tomography for alzheimer disease vs other neurodegenerative disorders[J]. JAMA, 2018, 320(11):1151-1162. Cited in this article [2]

[15]	de Wilde A, van der Flier WM, Pelkmans W, et al. Association of amyloid positron emission tomography with changes in diagnosis and patient treatment in an unselected memory clinic cohort: the ABIDE project[J]. JAMA Neurol, 2018, 75(9):1062-1070. Cited in this article [1]

[16]	La Joie R, Visani AV, Baker SL, et al. Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET[J]. Sci Transl Med, 2020, 12(524):eaau5732. Cited in this article [1]

[17]	Schaffer C, Sarad N, DeCrumpe A, et al. Biomarkers in the diagnosis and prognosis of Alzheimer's disease[J]. J Lab Autom, 2015, 20(5):589-600. Cited in this article [1]

[18]	Huang LK, Kuan YC, Lin HW, et al. Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update[J]. J Biomed Sci, 2023, 30(1):83. Cited in this article [1]

[19]	Sevigny J, Chiao P, Bussière T, et al. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease[J]. Nature, 2016, 537(7618):50-56. Cited in this article [1]

[20]	Söderberg L, Johannesson M, Nygren P, et al. Lecanemab, aducanumab, and gantenerumab - binding profiles to different forms of amyloid-beta might explain efficacy and side effects in clinical trials for Alzheimer's disease[J]. Neurotherapeutics, 2023, 20(1):195-206. Cited in this article [1]

[21]	Zhang M, Zhao D, Zhou G, et al. Dietary pattern, gut microbiota, and Alzheimer's disease[J]. J Agric Food Chem, 2020, 68(46):12800-12809. Cited in this article [1]

[22]	Wu S, Liu X, Jiang R, et al. Roles and mechanisms of gut microbiota in patients with Alzheimer's disease[J]. Front Aging Neurosci, 2021,13:650047. Cited in this article [1]

[23]	Blander JM, Longman RS, Iliev ID, et al. Regulation of inflammation by microbiota interactions with the host[J]. Nat Immunol, 2017, 18(8):851-860. Cited in this article [1]

[24]	Calvani R, Picca A, Lo Monaco MR, et al. Microbes and minds: a narrative review on the second brain aging[J]. Front Med, 2018,5:53. Cited in this article [2]

[25]	Mancuso C, Santangelo R. Alzheimer' s disease and gut microbiota modifications: The long way between preclinical studies and clinical evidence[J]. Pharmacol Res, 2018,129:329-336. Cited in this article [1]

[26]	Wang X, Sun G, Feng T, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression[J]. Cell Res, 2019, 29(10):787-803. Cited in this article [2]

[27]	Kesika P, Suganthy N, Sivamaruthi BS, et al. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease[J]. Life Sci, 2021,264:118627. Cited in this article [1]

[28]	Shen H, Guan Q, Zhang X, et al. New mechanism of neuroinflammation in Alzheimer's disease: the activation of NLRP3 inflammasome mediated by gut microbiota[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2020,100:109884. Cited in this article [1]

[29]	Bosch ME, Dodiya HB, Michalkiewicz J, et al. Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner[J]. Mol Neurodegener, 2024, 19(1):18. Cited in this article [1]

[30]	李选, 王泽颖, 魏洪玉, 等. 王泽颖采用扶正化痰祛瘀法治疗血管性痴呆经验[J]. 湖北中医杂志, 2023, 45(11):29-32. Cited in this article [1]

[31]	向岁, 王平, 石和元, 等. 血管性痴呆的中西医研究进展[J]. 中西医结合心脑血管病杂志, 2022, 20(18):3352-3356. Cited in this article [1]

[32]	许良贤, 慎松, 蒋跃希, 等. 益肾祛痰方联合双嘧达莫治疗血管性痴呆作用机制探讨[J]. 湖北中医药大学学报, 2022, 24(4):19-22. Cited in this article [1]

[33]	周雨慧, 李晓宁. 从“肾虚玄闭、神机不遂”谈血管性痴呆的辨治思路[J]. 河北中医药学报, 2023, 38(5):10-13. Cited in this article [1]

[34]	李莉, 王锋. 益肾补脑汤联合五神针治疗血管性痴呆临床观察[J]. 光明中医, 2023, 38(13):2549-2552. Cited in this article [1]

[35]	潘露茜, 顾耘, 林水淼, 等. 林水淼教授补益精血法治疗老年杂病学验[J]. 中国中医药现代远程教育, 2015, 13(1): 24-27. Cited in this article [1]

[36]	班维固, 齐辉, 滕秀英, 等. 参苓养心汤联合针刺治疗心脾两虚型血管性痴呆45例[J]. 环球中医药, 2022, 15(4):689-692. Cited in this article [2]

[37]	史宏硕. 交泰益智汤治疗心肾不交型血管性痴呆的临床研究[D]. 山东: 山东中医药大学, 2023. Cited in this article [1]

[38]	杨兴才, 李宁, 徐世芬, 等. 调心方治疗轻度老年痴呆症疗效观察[J]. 中医学报, 2018, 33(10):2020-2024. Cited in this article [1]

[39]	唐星明. 黎介寿院士的学术成就与学术思想追忆[J]. 肠外与肠内营养, 2023, 30(1):6-7. Cited in this article [2]

[40]	张丽梅, 胡元会, 陈锦, 等. 王永炎教授学术思想及临证经验总结[J]. 中国当代医药, 2018, 25(1):139-143. Cited in this article [1]

[41]	孙永康, 王新志. 王新志从“胃”论治脑病学术观点探析[J]. 中医杂志, 2020, 61(24):2140-2144. Cited in this article [1]

[42]	任金凤, 刘晓语, 游录妍, 等. 地黄饮子防治阿尔茨海默病和帕金森病的研究进展[J]. 中国药理学与毒理学杂志, 2023, 37(S1):63-64. Cited in this article [1]

[43]	吴秀锋, 张新彦, 孙成晖, 等. 补肾益智汤联合针灸诱导下调脑区激活促阿尔兹海默病脑功能康复的研究[J]. 黑龙江医药, 2023, 36(1):20-23. Cited in this article [1]

[44]	刘相玲, 徐长江, 杨玲玲, 等. 龟鹿二仙汤加减联合针刺治疗阿尔茨海默病疗效观察[J]. 中医临床研究, 2020, 12(21):92-93. Cited in this article [1]

[45]	周西彬. 苓桂术甘汤调控阿尔兹海默病病理进程中中枢神经元自噬的生物学机制研究[D]. 南京: 南京中医药大学, 2021. Cited in this article [1]

[46]	桑星晨. 黄芪散拆方对阿尔兹海默病的防治作用[D]. 上海: 上海中医药大学, 2019. Cited in this article [1]

[47]	刘璐. 健脾补肾益智方治疗脾肾阳虚型阿尔兹海默病的临床疗效观察[D]. 广西: 广西中医药大学, 2019. Cited in this article [1]

[48]	卢慧, 于莹, 程肖蕊, 等. 中药复方聪明汤的研究进展[J]. 中国药理学与毒理学杂志, 2023, 37(S1):63. Cited in this article [1]

[49]	胡怡然. 新调心方通过CD38-NAD-+通路干预早期阿尔茨海默病能量代谢障碍的机制研究[D]. 上海: 上海中医药大学, 2021. Cited in this article [1]

[50]	李紫丞, 王艳华. 复方苁蓉益智胶囊联合多奈哌齐对阿尔兹海默病的疗效[J]. 河南医学研究, 2020, 29(5):873-874. Cited in this article [1]

[51]	宋志勇, 穆亚敏. 补阳还五汤对阿尔茨海默病小鼠行为学及脑组织能量代谢和线粒体的影响[J]. 现代养生, 2023, 23(10):730-733. Cited in this article [1]

[52]	刘慧瑛. 化痰开窍方治疗痰浊蒙窍型阿尔茨海默病的疗效观察[D]. 上海: 上海中医药大学, 2021. Cited in this article [1]

[53]	程美佳, 袁常斌, 鞠业涛, 等. 涤痰汤通过调节IKB/NF-κB通路和细胞凋亡抑制阿尔茨海默病小鼠Tau蛋白过度磷酸化[J]. 时珍国医国药, 2024, 35(2):270-274. Cited in this article [1]